228 related articles for article (PubMed ID: 27305776)
1. [Regulation and evasion of host immune responses by Epstein-Barr virus].
Xiao N; Chen Q; Cai S
Wei Sheng Wu Xue Bao; 2016 Jan; 56(1):19-25. PubMed ID: 27305776
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus lytic infection promotes activation of Toll-like receptor 8 innate immune response in systemic sclerosis monocytes.
Farina A; Peruzzi G; Lacconi V; Lenna S; Quarta S; Rosato E; Vestri AR; York M; Dreyfus DH; Faggioni A; Morrone S; Trojanowska M; Farina GA
Arthritis Res Ther; 2017 Feb; 19(1):39. PubMed ID: 28245863
[TBL] [Abstract][Full Text] [Related]
3. Immune Evasion by Epstein-Barr Virus.
Ressing ME; van Gent M; Gram AM; Hooykaas MJ; Piersma SJ; Wiertz EJ
Curr Top Microbiol Immunol; 2015; 391():355-81. PubMed ID: 26428381
[TBL] [Abstract][Full Text] [Related]
4. Understanding the interplay between host immunity and Epstein-Barr virus in NPC patients.
Shen Y; Zhang S; Sun R; Wu T; Qian J
Emerg Microbes Infect; 2015 Mar; 4(3):e20. PubMed ID: 26038769
[TBL] [Abstract][Full Text] [Related]
5. Innate Immune Recognition of EBV.
Lünemann A; Rowe M; Nadal D
Curr Top Microbiol Immunol; 2015; 391():265-87. PubMed ID: 26428378
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus large tegument protein BPLF1 contributes to innate immune evasion through interference with toll-like receptor signaling.
van Gent M; Braem SG; de Jong A; Delagic N; Peeters JG; Boer IG; Moynagh PN; Kremmer E; Wiertz EJ; Ovaa H; Griffin BD; Ressing ME
PLoS Pathog; 2014 Feb; 10(2):e1003960. PubMed ID: 24586164
[TBL] [Abstract][Full Text] [Related]
7. Immune activation suppresses initiation of lytic Epstein-Barr virus infection.
Ladell K; Dorner M; Zauner L; Berger C; Zucol F; Bernasconi M; Niggli FK; Speck RF; Nadal D
Cell Microbiol; 2007 Aug; 9(8):2055-69. PubMed ID: 17419714
[TBL] [Abstract][Full Text] [Related]
8. The long-lasting love affair between the budding yeast Saccharomyces cerevisiae and the Epstein-Barr virus.
Lista MJ; Voisset C; Contesse MA; Friocourt G; Daskalogianni C; Bihel F; Fåhraeus R; Blondel M
Biotechnol J; 2015 Sep; 10(11):1670-81. PubMed ID: 26311489
[TBL] [Abstract][Full Text] [Related]
9. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
Niller HH; Wolf H; Minarovits J
Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
[TBL] [Abstract][Full Text] [Related]
10. Genetics of Epstein-Barr virus infection.
Hiraki A; Fujii N; Masuda K; Ikeda K; Tanimoto M
Biomed Pharmacother; 2001 Sep; 55(7):369-72. PubMed ID: 11669499
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus induces the differentiation of semi-mature dendritic cells from cord blood monocytes.
Jin YY; Wang X; Du J; Cao RM; Law HK; Wang JJ; Chen TX
Hum Immunol; 2014 Apr; 75(4):306-16. PubMed ID: 24530751
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr Virus miR-BART6-3p Inhibits the RIG-I Pathway.
Lu Y; Qin Z; Wang J; Zheng X; Lu J; Zhang X; Wei L; Peng Q; Zheng Y; Ou C; Ye Q; Xiong W; Li G; Fu Y; Yan Q; Ma J
J Innate Immun; 2017; 9(6):574-586. PubMed ID: 28877527
[TBL] [Abstract][Full Text] [Related]
13. Molecular diversity of IgG responses to Epstein-Barr virus proteins in asymptomatic Epstein-Barr virus carriers.
Goswami R; Shair KHY; Gershburg E
J Gen Virol; 2017 Sep; 98(9):2343-2350. PubMed ID: 28795661
[TBL] [Abstract][Full Text] [Related]
14. Characterization of Epstein-Barr virus (EBV) BZLF1 gene promoter variants and comparison of cellular gene expression profiles in Japanese patients with infectious mononucleosis, chronic active EBV infection, and EBV-associated hemophagocytic lymphohistiocytosis.
Imajoh M; Hashida Y; Murakami M; Maeda A; Sato T; Fujieda M; Wakiguchi H; Daibata M
J Med Virol; 2012 Jun; 84(6):940-6. PubMed ID: 22511310
[TBL] [Abstract][Full Text] [Related]
15. EBV lytic-phase protein BGLF5 contributes to TLR9 downregulation during productive infection.
van Gent M; Griffin BD; Berkhoff EG; van Leeuwen D; Boer IG; Buisson M; Hartgers FC; Burmeister WP; Wiertz EJ; Ressing ME
J Immunol; 2011 Feb; 186(3):1694-702. PubMed ID: 21191071
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus suppresses N
Zhang X; Li Z; Peng Q; Liu C; Wu Y; Wen Y; Zheng R; Xu C; Tian J; Zheng X; Yan Q; Wang J; Ma J
J Biol Chem; 2024 May; 300(5):107226. PubMed ID: 38537697
[TBL] [Abstract][Full Text] [Related]
17. The role of Epstein-Barr virus in epithelial malignancies.
Tsao SW; Tsang CM; To KF; Lo KW
J Pathol; 2015 Jan; 235(2):323-33. PubMed ID: 25251730
[TBL] [Abstract][Full Text] [Related]
18. Multiple roles of LMP1 in Epstein-Barr virus induced immune escape.
Middeldorp JM; Pegtel DM
Semin Cancer Biol; 2008 Dec; 18(6):388-96. PubMed ID: 19013244
[TBL] [Abstract][Full Text] [Related]
19. [Factors involved in host-pathogen interaction for the risk of Hodgkin lymphoma induced by Epstein Barr virus].
Torres Espíndola LM; Arellano Galindo J; Velazquez Cruz R; Castillejos López Mde J
Invest Clin; 2013 Sep; 54(3):311-24. PubMed ID: 24354244
[TBL] [Abstract][Full Text] [Related]
20. Human B cells on their route to latent infection--early but transient expression of lytic genes of Epstein-Barr virus.
Kalla M; Hammerschmidt W
Eur J Cell Biol; 2012 Jan; 91(1):65-9. PubMed ID: 21450364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
